^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Male Breast Cancer |
| Drug Class: | HER2 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Preoperative/adjuvant systemic therapy: Chemotherapy with/without HER2-targeted therapy should be recommended for men with breast cancer according to guidelines for women with breast cancer according to guidelines for women with breast cancer.
